Variant report
Variant | esv3348247 |
---|---|
Chromosome Location | chr5:114734703-114737001 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:37)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:37 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr5:114734352-114734795 | IMR90 | lung: | n/a | n/a |
2 | CEBPB | chr5:114734428-114734730 | Hela-S3 | cervix: | n/a | n/a |
3 | EP300 | chr5:114734246-114735071 | SK-N-SH | brain: | n/a | n/a |
4 | EP300 | chr5:114734503-114734765 | SK-N-SH_RA | brain: | n/a | n/a |
5 | EP300 | chr5:114734404-114734790 | SK-N-SH_RA | brain: | n/a | n/a |
6 | EP300 | chr5:114734364-114734999 | SK-N-SH | brain: | n/a | n/a |
7 | EP300 | chr5:114734233-114734937 | SK-N-SH | brain: | n/a | n/a |
8 | FOS | chr5:114734501-114734781 | MCF10A-Er-Src | breast: | n/a | n/a |
9 | FOS | chr5:114734509-114734782 | MCF10A-Er-Src | breast: | n/a | n/a |
10 | FOSL2 | chr5:114734392-114734831 | SK-N-SH | brain: | n/a | n/a |
11 | FOSL2 | chr5:114734385-114734989 | SK-N-SH | brain: | n/a | n/a |
12 | FOXM1 | chr5:114734369-114735130 | SK-N-SH | brain: | n/a | n/a |
13 | FOXM1 | chr5:114734470-114734821 | SK-N-SH | brain: | n/a | n/a |
14 | GATA3 | chr5:114734016-114735167 | SK-N-SH | brain: | n/a | n/a |
15 | GATA3 | chr5:114734209-114734968 | SK-N-SH | brain: | n/a | n/a |
16 | JUND | chr5:114734317-114735007 | SK-N-SH | brain: | n/a | n/a |
17 | JUND | chr5:114734125-114735043 | SK-N-SH | brain: | n/a | n/a |
18 | JUND | chr5:114734295-114734986 | SK-N-SH | brain: | n/a | n/a |
19 | MAX | chr5:114734460-114734834 | SK-N-SH | brain: | n/a | n/a |
20 | MEF2A | chr5:114734386-114734964 | SK-N-SH | brain: | n/a | n/a |
21 | MYC | chr5:114734502-114734805 | MCF10A-Er-Src | breast: | n/a | n/a |
22 | MYC | chr5:114734545-114734763 | MCF10A-Er-Src | breast: | n/a | n/a |
23 | NFIC | chr5:114734398-114734949 | SK-N-SH | brain: | n/a | n/a |
24 | NFIC | chr5:114734384-114734988 | SK-N-SH | brain: | n/a | n/a |
25 | PBX3 | chr5:114734361-114734872 | SK-N-SH | brain: | n/a | n/a |
26 | PBX3 | chr5:114734282-114734959 | SK-N-SH | brain: | n/a | n/a |
27 | POLR2A | chr5:114734401-114734772 | U87 | brain: | n/a | n/a |
28 | POLR2A | chr5:114734511-114734745 | SK-N-SH | brain: | n/a | n/a |
29 | POLR2A | chr5:114734357-114734860 | SK-N-SH | brain: | n/a | n/a |
30 | RXRA | chr5:114734359-114734838 | SK-N-SH | brain: | n/a | n/a |
31 | SIN3AK20 | chr5:114734488-114734812 | SK-N-SH | brain: | n/a | n/a |
32 | TAF1 | chr5:114734513-114734794 | SK-N-SH | brain: | n/a | n/a |
33 | TCF12 | chr5:114734184-114735076 | SK-N-SH | brain: | n/a | n/a |
34 | TCF12 | chr5:114734243-114735047 | SK-N-SH | brain: | n/a | n/a |
35 | TEAD4 | chr5:114734365-114734905 | SK-N-SH | brain: | n/a | n/a |
36 | TEAD4 | chr5:114734346-114734987 | SK-N-SH | brain: | n/a | n/a |
37 | YY1 | chr5:114734464-114734847 | SK-N-SH | brain: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
AK3P4 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs576211138 | chr5:114734709-114734710 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs576257143 | chr5:114734724-114734725 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs564983527 | chr5:114734762-114734763 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs2416408 | chr5:114734784-114734785 | Enhancers Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs2416409 | chr5:114734802-114734803 | Enhancers Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs560884249 | chr5:114734817-114734818 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs529903181 | chr5:114734824-114734825 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs2416410 | chr5:114734832-114734833 | Enhancers Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs569667035 | chr5:114734862-114734863 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs116542399 | chr5:114734864-114734865 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs552430907 | chr5:114734868-114734869 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs116025650 | chr5:114734917-114734918 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs181322967 | chr5:114734928-114734929 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs79498092 | chr5:114734945-114734946 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs544752058 | chr5:114734974-114734975 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs143494105 | chr5:114734993-114734994 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs2963755 | chr5:114734994-114734995 | Enhancers Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs527309342 | chr5:114734995-114734996 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs148888848 | chr5:114735006-114735007 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs569518231 | chr5:114735013-114735014 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs143284437 | chr5:114735036-114735037 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs4431333 | chr5:114735074-114735075 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs538627424 | chr5:114735084-114735085 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs35324957 | chr5:114735093-114735094 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs558399790 | chr5:114735112-114735113 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs376266814 | chr5:114735123-114735124 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs572093614 | chr5:114735127-114735128 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs114432157 | chr5:114735171-114735172 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs141520488 | chr5:114735188-114735189 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs4418090 | chr5:114735222-114735223 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs561249635 | chr5:114735230-114735231 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs370081564 | chr5:114735236-114735237 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs372716707 | chr5:114735247-114735248 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs4626329 | chr5:114735272-114735273 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs138308750 | chr5:114735307-114735308 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs13164257 | chr5:114735359-114735360 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs70976372 | chr5:114735368-114735369 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs200439367 | chr5:114735369-114735370 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs201445330 | chr5:114735370-114735371 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs199767690 | chr5:114735371-114735372 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs189189414 | chr5:114735425-114735426 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs62372563 | chr5:114735443-114735444 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs62372564 | chr5:114735451-114735452 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs181884578 | chr5:114735460-114735461 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs552522106 | chr5:114735462-114735463 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs559624940 | chr5:114735477-114735478 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs187393632 | chr5:114735479-114735480 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs62372565 | chr5:114735481-114735482 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs79530269 | chr5:114735482-114735483 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs74613330 | chr5:114735543-114735544 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Colorectal cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Prostate cancer | 16461572 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Sezary syndrome | 18413736 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:114729600-114737000 | Weak transcription | NHLF | lung |
2 | chr5:114730000-114737800 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
3 | chr5:114731200-114738000 | Weak transcription | Lung | lung |
4 | chr5:114732000-114735200 | Enhancers | NHDF-Ad | bronchial |
5 | chr5:114732800-114738000 | Weak transcription | HSMM | muscle |
6 | chr5:114733000-114738000 | Weak transcription | NH-A | brain |
7 | chr5:114733000-114738000 | Weak transcription | Osteobl | bone |
8 | chr5:114733800-114735000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
9 | chr5:114734200-114735000 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
10 | chr5:114734200-114735000 | Enhancers | Muscle Satellite Cultured Cells | -- |
11 | chr5:114735000-114737800 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
12 | chr5:114735000-114738000 | Weak transcription | Muscle Satellite Cultured Cells | -- |
13 | chr5:114735000-114738200 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
14 | chr5:114735200-114737800 | Weak transcription | NHDF-Ad | bronchial |
15 | chr5:114737000-114737200 | Enhancers | NHLF | lung |